It is the last week of June 2026, and the micro-cap markets are functioning exactly as designed: as a vast, highly efficient machine for converting retail equity into subordinated debt. This week's filings are a masterclass in delayed inevitability. From SPACs that refuse to liquidate to commercial real estate portfolios bleeding out one loan modification at a time, we are seeing what happens when the runway finally runs out.
FiscalNote Holdings (NOTE): The Delisting Double-Whammy
If you are going to get kicked off the New York Stock Exchange, try not to have a covenant in your convertible debt that says 'if we get delisted, you must pay us back immediately.' FiscalNote received its delisting notice earlier this year after its stock price languished below a dollar, and the immediate consequence was tripping defaults on its subordinated convertible notes. Last week, the company announced an amended forbearance agreement with those lenders. The catch? The forbearance only lasts until July 21, 2026. The company just swapped in a new CEO, Key Compton, to oversee the mess as they trade on the OTC markets. When your lenders are giving you month-to-month forbearance, you aren't running a software business; you are running a controlled demolition.
Alpha Modus Holdings (AMOD): The Streeterville Special
In December 2024, Alpha Modus consummated a SPAC merger and immediately celebrated by issuing a $2.89 million secured convertible note to Streeterville Capital. The terms were a classic death spiral: floating conversion prices, full security over the company's intellectual property, and a 1% monthly principal penalty for registration delays. Predictably, the equity has been a disaster. The primary function of a public listing in these situations is simply to give your subordinated creditors a liquid currency to sell. By mid-June 2026, AMOD was forced to execute a 1-for-40 reverse split just to maintain a pulse, and the stock recently plunged another 15% in a single day. The company is currently pumping out press releases about its 'Alpha Cash' kiosks for the unbanked, but the real story here is the capitalization table. The equity is merely a funding mechanism for the noteholder.
KBS Real Estate Investment Trust III (KBSR): The Perpetual Modification
When you are on the fifth modification of a revolving loan facility that was already heavily modified, you are essentially a ward of your lenders. KBS REIT III warned of substantial doubt about its ability to continue as a going concern back in early 2025, citing massive commercial real estate debt maturities. The rolling disaster has continued unabated. As of spring 2026, the REIT is still explicitly warning shareholders about the risk of a Chapter 11 filing. They have resorted to dumping assets—like selling off the Gateway Tech Center for $50 million—just to chip away at the $1.3 billion in near-term debt. The equity here is essentially an out-of-the-money call option on commercial real estate interest rates.
Scilex Holding Co (SCLX): The Auditor Two-Step
In the real world, firing Ernst & Young over accounting irregularities and defaulting on your senior debt is a catastrophe. In micro-cap biotech, it is just a speed bump. Scilex blew up in late 2024 over contract investigations and missed filings, but they have since managed a remarkable zombie pivot. They placated Oramed and their secured noteholders with maturity extensions to late 2025, swapped in a new auditor, and by April 2026, brazenly filed a $500 million shelf registration. Last week, they held their 2026 annual meeting to expand their equity incentive plan, despite posting a Q1 loss of nearly $5 a share. Never underestimate the resilience of a biotech company that still has a ticker symbol to dilute.
Newbury Street Acquisition Corp (NBST): The Zombie SPAC
You would think a 'liquidation deadline' of March 25, 2025, means a SPAC actually liquidates in March 2025. You would be wrong. After its merger with Infinite Reality collapsed in late 2024, NBST pocketed a $7 million termination fee and simply refused to die. The company just kept holding special meetings to extend its life, most recently pushing its deadline out to March 2026 while bleeding trust assets to redemptions along the way. It is a wandering ghost of the 2021 SPAC boom, existing purely to collect interest and pay proxy solicitors.
What to Watch
Keep a close eye on FiscalNote's July 21 forbearance deadline. When lenders give you a leash measured in days, they usually have a pre-packaged restructuring plan already drafted in their outbox. Otherwise, expect another week of highly dilutive convertibles, reverse splits, and management teams pretending that a month-to-month loan extension is a sign of fundamental strength.